VP Natus Medical Inc. is Selling Shares

By George MacDonald

Yesterday, vP Natus Medical Inc., Kenneth Traverso, sold stocks of BABY for $2.33M.

Following Traverso’s last BABY Sell transaction on January 06, 2015, the stock climbed by 3.2%. In addition to Traverso, 2 other BABY executives reported Sell trades in the last month.

Based on Natus Medical Inc.`s latest earnings report from December 31, the company posted quarterly revenue of $94.01M and quarterly net profit of $10.7M. In comparison, last year the company earned revenue of $85.62M and had a net profit of $6.25M. The company has a one year high of $$42.96 and a one year low of $$23.40. BABY’s market cap is $1.3B and the company has a P/E ratio of 37.3%.

Based on 1 analyst ratings, the analyst consensus is Strong Buy with an average price target of $45.00, reflecting a -16.2% downside.

Looking at blogger coverage of BABY, there is a 100% Bullish tendency on the stock, in relation to a 67% average bullish tendency within the Healthcare sector.

In the last 30 days, insiders have sold $2.97M worth of BABY shares and purchased $495.6k worth of BABY shares. Over the last 3 months, the insider sentiment on Natus Medical Inc. has been neutral based on 27 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Natus Medical Inc provides newborn care & neurology healthcare products & services used for screening, diagnosis, detection, treatment, monitoring & tracking of medical ailments in newborn care, epilepsy, sleep disorders, and balance & mobility disorders.